Your browser doesn't support javascript.
loading
Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials.
Yu, Jiahui; Li, Mengnan; Ren, Boxu; Cheng, Le; Wang, Xiaoxiao; Ma, Zhaowu; Yong, Wei Peng; Chen, Xiaoguang; Wang, Lingzhi; Goh, Boon Cher.
Afiliación
  • Yu J; School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.
  • Li M; School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.
  • Ren B; School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.
  • Cheng L; School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.
  • Wang X; School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.
  • Ma Z; School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.
  • Yong WP; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Chen X; NUS Center for Cancer Research (N2CR), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Wang L; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Goh BC; School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.
Front Pharmacol ; 14: 1261575, 2023.
Article en En | MEDLINE | ID: mdl-37719852
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article